Clinical Trial Update: Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the safety and efficacy of combining alogliptin with pioglitazone in adults with Type 2 diabetes mellitus has completed, with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Actos (pioglitazone) (pioglitazone)
• Nesina (alogliptin) (Alogliptin)

Snippet

Sponsor: Takeda | Conditions: Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2011-09-27